INSIGHTS ON DRUG DEVELOPMENT

• Method Development For Forced Degradation Of GLP-1 Agonist

  Gain insight into how a systematic approach reveals impurity behavior, strengthens selectivity, and refines chromatographic conditions to build a reliable degradation method for a GLP‑1 agonist.

• Advancing Multiomics Through Intelligent Automation

  Modern automation tackles hidden pipetting errors and boosts reproducibility. Discover how your lab can scale confidently, reduce rework, and accelerate multiomic workflows with built-in traceability.

• Denaturing SEC-MS Analysis Of High Molecular Weight Impurities

  Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.

• Overcoming Gene Therapy Cost Roadblocks On The Path To Patients

  Viral vector-based gene therapies are expanding beyond rare diseases to treat larger populations. Discover how innovations in manufacturing are making these life-changing treatments more accessible.

• Redefining OSD Development Through Foresight And Innovation

  2/12/2026

  From early formulation challenges to scale-up and commercial readiness, proactive planning and integrated capabilities help teams anticipate risks, accelerate decision-making, and maintain momentum across development.

• Doubling Up For Speed In Biomanufacturing

  12/12/2025

  Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.

• Aggregation In Antibody-Drug Conjugates: Causes And Mitigation

  9/1/2025

  Discover how early intervention in ADC development can streamline clinical progress, ensure stability and safety, and accelerate commercialization with expert guidance.

• Accelerated Yield Optimization Of Affinity Capture

  5/15/2026

  High‑throughput affinity screening shows how buffer and pH optimization can boost AAV5 recovery, enabling faster, more reliable downstream process development for challenging serotypes.

• Measuring Thermodynamic Parameters In The Drug Development Process

  4/29/2025

  Join Dr. Ladbury to explore how thermodynamic data can enhance our understanding of protein-ligand interactions and how it is crucial for optimizing drug efficacy and safety in pharmaceutical development.